- Info
- Significant Ownership
- Financials
- Holders
Significant Ownership of NOVO NORDISK A S
- Signature - Title
- /s/ Karsten Munk Knudsen - Karsten Munk Knudsen, Chief Financial Officer
- Location
- Bagsvaerd Denmark, Denmark
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by NOVO NORDISK A S.
Follow Filing Activity
Follow NOVO NORDISK A S and return when a new Schedule 13D/G filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Continue schedule research
Related filing hubs for this reporting manager, useful for reinforcing crawl paths across the schedule cluster.
Significant Ownership of NOVO NORDISK A S
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| Innate Pharma SA | Ordinary Shares, nominal value (euro) 0.05 per share (including ordinary shares represented by American Depositary Shares) | 7.8% | 7,333,778 | -18% | Novo Nordisk A/S | 31 Dec 2025 |
Schedules 13D/G Reported by NOVO NORDISK A S:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.